Pharmafile Logo
Pharmafocus logo
Advanced Search

Phase III trial results gives hope to B-Cell lymphoma patients

December 14, 2021
Manufacturing and Production

Bristol Myers Squibb (BMS) reported that interim assessment data from the Phase III TRANSFORM clinical trial of Breyanzi (lisocabtagene maraleucel; …

News
astrazeneca_plaque

Samsung Biologics and AstraZeneca expand partnership to include COVID-19 and cancer therapy

December 14, 2021
Medical Communications

Contract development and manufacturing organisation (CDMO), Samsung Biologics, and AstraZeneca, continue their strategic collaboration which was initiated in May 2021. …

News
chris_hewitt_head_shot

Amarin appoints Dr Chris Hewitt UK and Ireland Medical Director

December 13, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Amarin has appointed Dr Chris Hewitt as UK and Ireland Medical Director. Hewitt is a UK-trained physician with many years …

Appointment
credit_-_crevis_shutterstock_340710245_720

CAR-T therapy trials show promise for earlier use in lymphoma

December 13, 2021
Sales and Marketing

Earlier use of chimeric antigen receptor (CAR) T-cell therapy for relapse B-cell lymphoma has demonstrated efficacy at substantially improving outcomes …

News

New clinical trial testing diabetes drug for reducing risk of Alzheimer’s

December 13, 2021
Sales and Marketing

A new study run by the Diabetes Trials Unit, and the Department of Psychiatry at the University of Oxford, alongside …

News

UK government sets new booster target

December 13, 2021
Sales and Marketing

The PM has announced that booster jabs will be offered to everyone over 18 in England from this week, and …

News

Feedback receives funding for cloud-based tuberculosis programme

December 13, 2021
Sales and Marketing

Specialist clinical communication company, Feedback, announced that it has partnered with Amazon Web Services (AWS) to establish and deliver cloud-based …

News

CDC authorise Pfizer boosters for 16- and 17-year-olds

December 10, 2021
Medical Communications

The FDA and CDC have authorised booster vaccinations of the Pfizer-BioNTech COVID-19 vaccine for teenagers aged 16 and 17. The …

News

FDA approves expansion for ZYNRELEF

December 10, 2021
Medical Communications

The FDA has approved Heron Therapeutics’ supplemental New Drug Application (sNDA) for ZYNRELEF (bupivacaine and meloxicam), to significantly expand the …

News

Novartis announces positive results from Phase III trial of Beovu

December 9, 2021
Business Services

Novartis have announced the first interpretable results from year two (week 100) of the Phase III KESTREL study. KESTREL assessed …

News

Pfizer says COVID-19 booster shot is promising against Omicron variant

December 9, 2021

The companies said that the three doses provide a similar level of antibodies against Omicron, compared to that of two …

News

FDA approval for first CGP test for melanoma therapeutics

December 9, 2021
Business Services

The FDA has granted Foundation Medicine approval for its companion diagnostic, FoundationOne®CDx, for two groups of current and future FDA-approved …

News

EUA granted to AstraZeneca’s antibody therapy for COVID-19 prevention

December 9, 2021
Business Services

AstraZeneca announced that its Evusheld antibody combination for the prevention of COVID-19 in immunocompromised adults and adolescents has been granted …

News

Abbott receives CE mark for traumatic brain injury blood test

December 8, 2021
Research and Development

Abbott has received a CE mark for its laboratory traumatic brain injury (TBI) blood test. This will be the first …

News
mat-napo-pij34zrzeew-unsplash

Positive Phase III trial results for plant-based COVID-19 vaccine candidate

December 8, 2021
Research and Development

The biopharmaceutical company Medicago, alongside GlaxoSmithKline, have announced positive efficacy and safety results from the global Phase III placebo-controlled efficacy …

News

Booster vaccines may be needed for ‘years to come’, says Pfizer

December 8, 2021
Research and Development

Ben Osborn, country manager for Pfizer in the UK, has shared that coronavirus booster jabs will likely be necessary “for …

News

WHO reject convalescent plasma treatment for COVID-19

December 7, 2021
Manufacturing and Production

WHO now strongly recommend against the use of convalescent plasma in the treatment of COVID-19 patients regardless of their stage …

News

Study reveals young people recover quickly from rare COVID-19 side effect

December 7, 2021
Manufacturing and Production

Most young people under the age of 21 who develop suspected COVID-19 myocarditis (inflammation of the muscle), show mild symptoms …

News

GSK antibody treatment effective against Omicron, study suggests

December 7, 2021
Manufacturing and Production

GlaxoSmithKline Plc have shared that research shows its antibody treatment is effective against the range of mutations in the recently-emerged …

News

Acadia Pharmaceuticals achieve positive Phase III results in Rett Syndrome trial

December 7, 2021
Manufacturing and Production

Acadia Pharmaceuticals have announced positive top-line results from the pivotal, Phase III Lavender study, which evaluated the efficacy and safety …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026